Curis | CRIS - Current Assets


Curis reported $16.61M in Current Assets for its fiscal quarter ending in March of 2026.





Current Assets Change Date
Alaunos Therapeutics USD 970K 1.02M Mar/2026
Amgen USD 34.96B 3.49B Jun/2026
AstraZeneca USD 27.97B 1.65B Jun/2026
Bayer EUR 33.64B 1.66B Jun/2026
Bristol-Myers Squibb USD 28.58B 1.37B Jun/2026
CSL USD 11.85B 1000K Dec/2025
Curis USD 16.61M 9.7M Mar/2026
Eli Lilly USD 64.67B 9.84B Jun/2026
Exelixis USD 1.25B 42.18M Jun/2026
Gilead Sciences USD 12.53B 6.11B Jun/2026
GlaxoSmithKline GBP 17.56B 202M Jun/2026
Incyte USD 6.03B 542.31M Jun/2026
Merck USD 36.68B 1.66B Jun/2026
Novartis USD 27.35B 744M Jun/2026
Pfizer USD 41.36B 1.46B Jun/2026
Roche Holding CHF 35.44B 3.29B Jun/2026
Sanofi EUR 31.52B 1.36B Jun/2026
Takeda JPY 3.15T 59.77B Jun/2026
TG Therapeutics USD 1.15B 58.72M Jun/2026
Verastem USD 202.9M 20.51M Mar/2026